Effects of epidural analgesia at 1 cm cervical dilatation on labor interventions in full-term primigravida: A retrospective cohort study

J Obstet Gynaecol Res. 2023 Jun;49(6):1545-1550. doi: 10.1111/jog.15640. Epub 2023 Mar 27.

Abstract

Objective: This study aimed to investigate the effects of epidural analgesia administered as early as cervical dilatation of 1 cm on labor interventions and maternal and neonatal outcomes.

Methods: This retrospective research recruited 1007 full-term primigravidas, who were distributed to two separate cohorts for eligibility: epidural analgesia 1 (cervical dilatation = 1 cm) and epidural analgesia 2 (cervical dilatation >1 cm). Labor interventions (artificial rupture of membranes and oxytocin administration) and duration of labor were the primary outcomes.

Results: The effect of initiation timing of epidural analgesia on artificial membrane rupture was not statistically significant (adjusted odds ratio [OR]: 0.85 [0.58-1.24], p > 0.05). Less oxytocin was used in the epidural analgesia 2 group compared with the epidural analgesia 1 group (the adjusted OR: 0.68 [0.49-0.95], p < 0.05). There were no significant differences in the median time to latent phase of labor, active phase of labor, second, and third stages of labor (p > 0.05). There were no significant differences in maternal and neonatal outcomes between the epidural analgesia 1 group and the epidural analgesia 2 group.

Conclusion: Epidural analgesia could be administered at cervical dilatation = 1 cm.

Keywords: artificial membrane rupture; cervical dilation; epidural analgesia; labor stage; use of oxytocin.

MeSH terms

  • Analgesia, Epidural*
  • Analgesia, Obstetrical*
  • Female
  • Humans
  • Infant, Newborn
  • Labor Stage, First
  • Labor, Obstetric*
  • Oxytocin / pharmacology
  • Pregnancy
  • Retrospective Studies

Substances

  • Oxytocin